Gaio, M.; Vastarella, M.G.; Sullo, M.G.; Scavone, C.; Riccardi, C.; Campitiello, M.R.; Sportiello, L.; Rafaniello, C.
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis. Pharmaceuticals 2024, 17, 904.
https://doi.org/10.3390/ph17070904
AMA Style
Gaio M, Vastarella MG, Sullo MG, Scavone C, Riccardi C, Campitiello MR, Sportiello L, Rafaniello C.
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis. Pharmaceuticals. 2024; 17(7):904.
https://doi.org/10.3390/ph17070904
Chicago/Turabian Style
Gaio, Mario, Maria Giovanna Vastarella, Maria Giuseppa Sullo, Cristina Scavone, Consiglia Riccardi, Maria Rosaria Campitiello, Liberata Sportiello, and Concetta Rafaniello.
2024. "Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis" Pharmaceuticals 17, no. 7: 904.
https://doi.org/10.3390/ph17070904
APA Style
Gaio, M., Vastarella, M. G., Sullo, M. G., Scavone, C., Riccardi, C., Campitiello, M. R., Sportiello, L., & Rafaniello, C.
(2024). Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis. Pharmaceuticals, 17(7), 904.
https://doi.org/10.3390/ph17070904
